Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Influenza Clinical Trials

A listing of Influenza medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (7) clinical trials

Participation in the DIAMOND Study may be open to those who: have started to get flu symptoms, such as cough, sore throat, stuffy nose, body aches, headache, fever, or tiredness are 13–65 years of age and have a long-term health condition (for example, a weakened immune system, lung disease, or ...


The Safety Tolerability and Pharmacokinetic Study of ZSP1273 in Healthy Volunteers.

The study will be divided in 3 parts : Study Part I(Single Ascending Dosing, SAD) will be a single ascending dose to be run at a maximum of 6 dose levels. Subjects included in this part of the study will receive only one dose level to limit the exposure to ...


Resistance Exercise to Improve Flu Vaccine for Older Adults

Resistance exercise, particularly novel eccentric exercise, recruits immune cells to the targeted muscle. The exercises selected here targets the deltoid and biceps brachii muscles-those same muscles that the flu vaccine is delivered to during typical vaccination.

Phase N/A

Seqirus 2017 H7N9 With/Without MF59 (R) in Healthy Males and Non-pregnant Females 18-64 Years of Age.

This is a randomized, double-blinded, Phase II study in healthy males and non-pregnant females, 18-64 years of age. This clinical trial is designed to assess the safety, reactogenicity, and immunogenicity of a pre-pandemic 2017 monovalent inactivated influenza A/H7N9 virus vaccine (2017 H7N9 IIV) manufactured by Seqirus Inc (Seqirus) administered at ...


Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitor

Solid cancer patients receiving immune checkpoint inhibitor or cytotoxic chemotherapy will be recruited 1:2 manner in two hospitals. Target numbers are 48 and 95, respectively. All the participants will be vaccinated for influenza during their chemotherapy when they meet inclusion criteria. All the participants will be asked if they have ...

Phase N/A

Assessment of Viral Shedding Week Following Administration of Live Attenuated Influenza Vaccine in Children

LAIV shedding studies in children could be an important way to confirm whether impediments to viral replication do indeed explain these observed reductions in vaccine effectiveness (VE), whether prior vaccination has any influence on replication and what future implications (if any) this might have for the UK paediatric LAIV programme. ...


CT18 Infant Influenza Priming Study in Vaccine Naive Infants

Children under 24 months of age suffer from an influenza burden (high morbidity and mortality) similar to that of the elderly, and have been identified as a high priority target for vaccination programs by Canada's National Advisory Committee on Immunization. There is evidence that a person's first exposure to influenza ...